Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
Diabetes, Obesity and Metabolism · 2026-01 · 28 (1) · 427-433
DOI: 10.1111/dom.70213 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 27.10.2025. Verfasst von Melissa-Rosina Pasqua und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology & Metabolism, McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Glucagon-Like Peptides, Hypoglycemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canada Research Chairs.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
There is little data on how semaglutide affects basal versus bolus insulin and dosing parameters in adults with type 1 diabetes on insulin pump therapy.
Methods
This is a post‐hoc analysis of a double‐blinded, randomised, crossover trial assessing semaglutide (up to 1 mg) versus placebo during automated insulin delivery (AID). This analysis focuses on the first 11 of 15 weeks where participants used their routine pump therapy with continuous glucose monitoring (CGM), where remote follow‐ups were performed on days 7, 21, 32, 56, 63, and 77 (± 4 days). Changes in insulin requirements, carbohydrate input, and pump parameters over time compared to baseline were assessed, as well as the frequency of parameter adjustments.
Results
Twenty‐six participants were included; 100% were using CGM and 81% using AID at baseline. Daily total and bolus insulin, along with carbohydrate input, were significantly reduced by day 7 and remained so, while basal was significantly reduced by day 32. By day 77, there was a median increase in carbohydrate ratios by 4.1% [−1.8, 7.7] and in correction factors by 11.2% [0.0, 20.8], and a reduction in pre‐programmed basal rates by 7.9% [−12.7, −4.2]. The median time spent in hypoglycemia was rarely >4% during these follow‐ups.
Conclusions
Insulin needs decrease rapidly upon initiation of semaglutide use in type 1 diabetes on pump therapy, predominantly due to bolus changes from less carbohydrate consumption. While diabetes technology helps to reduce hypoglycemia, adjustments to pump dosing are still required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology & Metabolism, McGill University Health Centre, Montreal, Quebec, Canada.
- The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
- Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
- Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Melissa-Rosina Pasqua, Michael A Tsoukas, Ahmad Haidar
Förderung
- Canada Research Chairs
Zitieren
APA
Pasqua, M. R., Tsoukas, M. A., & Haidar, A. (2026). Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial. Diabetes, Obesity and Metabolism, 28(1), 427-433. https://doi.org/10.1111/dom.70213
Vancouver
Pasqua MR, Tsoukas MA, Haidar A. Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial. Diabetes, Obesity and Metabolism. 2026;28(1):427-433. doi:10.1111/dom.70213
BibTeX
@article{Pasqua2026,
author = {Pasqua, Melissa-Rosina and Tsoukas, Michael A and Haidar, Ahmad},
title = {Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {1},
pages = {427--433},
doi = {10.1111/dom.70213}
}
EUVIMED